MedTech Innovation and EU Investments
Shape the Future
Medical technologies are revolutionising healthcare, delivering innovative solutions that enhance diagnosis, treatment and patient care. From groundbreaking diagnostic tools to advanced surgical devices, MedTech innovations are transforming the healthcare landscape by making it more efficient, precise, and accessible.
Funding Opportunities For MedTech
The EU has demonstrated consistent support for Medtech R&D through strategic initiatives and substantial investments totaling billions of euros, aiming to foster innovation in medical technologies. Despite stringent regulatory compliance, the commitment to advancing healthcare innovation remains stronger than ever before. These efforts underscore the EU's strategic approach to maintaining competitiveness and driving technological advancement in healthcare.
We Can Support You
Nordic Innovators has extensive experience working with clients within the Life Science sector and we can help you to pursue EU soft funding.
You can be active on a variety of medical devices, therapeutics and advanced diagnostics projects such as:
- Molecular diagnostics, imaging systems and point-of-care devices, also including AI-driven models.
- Regenerative medicine technologies, such as tissue engineering, bio-printing, cell-based therapeutics.
- Innovative wearables, implantable sensors, health monitoring systems.
- Prosthetic implants, robotic surgical devices and related production systems.
Key EU Funding Programmes for Life Science
It gives grants and equity funding to innovative startups and SMEs with high impact/risk products or services. A unique combination of funding from €0.5 to 17.5 million to support innovative, products, services or business models that can create new markets or disrupt existing ones. New application process - 3 main stages.
Aimed for international projects that accelerate marketable innovative products. It is entry point enabling SMEs to merge and share expertise across borders. The consortium must have partners based in at least two different Eurostars countries. Funding average ranges of 50-75% of project costs.
This programme gives funding to turn research results into innovation opportunities. The goal is to help mature the technologies and develop business cases for the future commercialization. This can be in any field of science/technology and deal with specific challenges in various strategic fields.
Both IA and RIA are main vehicles for project-based collaborative technology development supported by the EC. IA is geared towards advancing innovative solutions towards market readiness and RIA is focused on pushing the boundaries of knowledge through pioneering research.
The programme consists of a combination of both open and challenge driven funding. It supports the exploration of bold ideas for radically new technologies and welcomes the high-risk and interdisciplinary cutting-edge science collaborations that underpin technological breakthroughs.
innovative health initiative
Innovative health initiative is a EU public-private partnership funding health research and innovation.
Organisations in the EU or Horizon Europe-associated countries including universities, research institutions, SMEs can apply for IHI funding. Larger companies may also qualify based on proposal calls.